Knowledge is limited about the lifetime risk of chronic pelvic pain syndrome (CPPS) occurrence in Chinese middle-aged males and the prognosis of CPPS patients with and without treatment. Noninstitutionalized Chinese males aged 40 to 81 years were enrolled in this study from a total of 76 local communities across 30 provinces of China. Information about […]
Renal colic is one of the most common complaints in patients admitted to Emergency Department (ED). Computed Tomography (CT) is the reference standard for the diagnosis of any stones in the kidneys or ureters. However, CT has classical disadvantages, such as radiation exposure, cost and availability. Recently, STONE clinical prediction criteria were suggested to identify […]
Renal cell carcinoma (RCC) is the 14th most common cancer in the world and the 7th most common cancer in high-income countries.1 According to the 2019 National Comprehensive Cancer Network (NCCN) and American Society for Clinical Oncology (ASCO),2,3 surgical resection is the standard of care for patients with localized kidney cancer, which typically involves removal […]
Until recently, robotic surgery has been associated only with the da Vinci robotic system. A novel Senhance® robotic system (TransEnterix Surgical Inc., Morrisville, NC, USA) was introduced almost 5 years ago.
To assess the safety and feasibility of the da Vinci SP (Intuitive Surgical, Sunnyvale, CA, USA) robotic platform for a consecutive series of patients who underwent single port robot-assisted laparoscopic radical prostatectomy (SP-RALP).
Since the introduction of the Da Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA) in 1999, the market for robot assisted laparoscopic surgery has grown with urology. The initial surgical advantage seen in adults was for robotic prostatectomy, and over time this expanded to the pediatric population with robotic pyeloplasty.
The purpose of this study was to compare perioperative and oncologic outcomes between laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy (RARC) for bladder cancer (BCa). Patients who underwent LRC or RARC with curative intent for BCa between January 2011 and December 2016 were included.
To evaluate the feasibility and safety of the application of robotic enucleation of adrenal masses (REAM). Thirteen patients at Shanghai Changhai Hospital who underwent robotic enucleation of adrenal mass from February 2017 to March 2018 were reviewed.
I am quite certain that every urologic surgeon in a teaching institution has been confronted by a patient stating, “I just want to be sure you are the one doing the surgery”. My response to this plea has been to explain the importance of medical teaching, assuring the patient that I am present from start […]
Robotic Assisted Laparoscopic Radical Prostatectomy (RALP) as the surgical intervention of choice for localised prostate cancer has led to the continued refinement and evolution of the technique in an attempt to improve oncological and functional outcomes. The Retzius space, named after the Swedish anatomist Anders Retzius (1796-1860) is the retropubic space within the preperitoneal area, […]
